Factors affecting platinum sensitivity in cervical cancer

Oncology Letters
Rina KatoIchio Fukasawa

Abstract

The present study aimed to investigate the association between nedaplatin (NDP) sensitivity and the expression of biological factors in cervical cancer. A total of 45 cervical cancer specimens, including 18 pretreatment biopsies and 27 surgical specimens, were used in histoculture drug response assays to determine the chemosensitivity of cervical cancer specimens to NDP. Each specimen was assessed for immunohistochemical expression of Ki-67, p53, B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), cleaved caspase-3, cyclooxygenase-2 (COX-2), and excision repair cross-complementation group 1 (ERCC1). The results revealed that low or negative expression of p53, Bcl-2 and COX-2, and high or positive expression of cleaved caspase-3 were significantly correlated with high sensitivity to NDP. However, there were no significant differences in Ki-67, Bax or ERCC1 expression between the low and high sensitivity groups. These findings indicate that sensitivity to platinum may be easily predicted by immunostaining for the detection of these specific factors in pretreatment biopsies or surgical specimens. The expression profiles of these targets may therefore provide additional information for planning individualized chemotherapy ...Continue Reading

References

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S M O'ReillyM A Richards
Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·R A VescioR M Hoffman
Oct 1, 1993·Critical Reviews in Oncology/hematology·R M Hoffman
Jan 1, 1994·The Journal of Cell Biology·J C Reed
Sep 2, 1993·The New England Journal of Medicine·F PezzellaD Y Mason
Oct 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E L LevineR D Hunter
Mar 1, 1996·American Journal of Clinical Pathology·J DieboldU Löhrs
Jan 1, 1996·Breast Cancer Research and Treatment·A BonettiG L Cetto
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R MetzgerL Leichman
Apr 1, 1998·Journal of the National Cancer Institute·D HwangE Levine
May 9, 1998·The Journal of Biological Chemistry·W L de LaatJ H Hoeijmakers
Feb 26, 1999·Journal of Cancer Research and Clinical Oncology·M R PillaiM K Nair
Oct 12, 1999·JAMA : the Journal of the American Medical Association·K M SheehanF E Murray
Jul 5, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·G MukherjeeM A Stanley
Oct 3, 2001·International Journal of Cancer. Journal International Du Cancer·J Y KimC H Kim
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FerrandinaF O Ranelletti
Mar 19, 2002·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Allen M Gown, Mark C Willingham
Feb 4, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H SultanaN Terakawa
Dec 24, 2003·The Cancer Journal·Tate Thigpen
May 11, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S NakadaS Nozawa
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M KanasugiS Nozawa
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·X Lu, A Feki
Sep 8, 2006·The New England Journal of Medicine·Ken A OlaussenUNKNOWN IALT Bio Investigators
Jan 19, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BellmuntUNKNOWN Spanish Oncology Genitourinary Group
Nov 3, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Min Kyoung KimSung-Bae Kim
Mar 13, 2009·General Thoracic and Cardiovascular Surgery·Tatsuya YoshimasuYoshitaka Okamura
Jul 4, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Karina Dahl SteffensenAnders Jakobsen
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkDavid Cella

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.